NuCana (NCNA) Stock Forecast & Price Target

$8.31

-0.41 (-4.70%)

(As of 10:42 AM ET)

NuCana - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Buy
Based on 2 Analyst Ratings

Based on 2 Wall Street analysts who have issued ratings for NuCana in the last 12 months, the stock has a consensus rating of "Buy." Out of the 2 analysts, 2 have given a buy rating for NCNA.

Consensus Price Target

$150.00
1,705.05% Upside

High Forecast	$150.00
Average Forecast	$150.00
Low Forecast	$150.00

According to the 2 analysts' twelve-month price targets for NuCana, the average price target is $150.00. The highest price target for NCNA is $150.00, while the lowest price target for NCNA is $150.00. The average price target represents a forecasted upside of 1,705.05% from the current price of $8.31.

Type	Current Forecast 8/23/23 to 8/22/24	1 Month Ago 7/24/23 to 7/23/24	3 Months Ago 5/25/23 to 5/24/24	1 Year Ago 8/23/22 to 8/23/23
Consensus Rating	Buy	Buy	Buy	Buy
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	2 Buy rating(s)	2 Buy rating(s)	2 Buy rating(s)	2 Buy rating(s)
Hold	0 Hold rating(s)	0 Hold rating(s)	0 Hold rating(s)	0 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$150.00	$150.00	$125.00	$75.00
Forecasted Upside	1,705.05% Upside	1,423.81% Upside	997.94% Upside	190.14% Upside

Get NuCana Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for NCNA and its competitors with MarketBeat's FREE daily newsletter.

Ad Colonial Metals

Wanted Dead: Petrodollar

The death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Russia, China and India have decided to abandon the petrodollar.

In answer to this issue, we have released a Special Report to the public.

NCNA Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

NCNA Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

NuCana Stock vs. The Competition

Type	NuCana	Medical Companies	S&P 500
Consensus Rating Score	3.00	2.75	2.51
Consensus Rating	Buy	Moderate Buy	Moderate Buy
Predicted Upside	1,620.18% Upside	5,591.76% Upside	8.74% Upside
News Sentiment Rating	Neutral News	Neutral News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Action	Rating	Price Target	Upside/Downside on Report Date
8/19/2024	Oppenheimer 3 of 5 stars	Reiterated Rating	Outperform ➝ Outperform	$150.00 ➝ $150.00	+4,078.26%
9/6/2023	Truist Financial 1 of 5 stars	Reiterated Rating	Buy ➝ Buy	$150.00	+795.66%
11/28/2022	Citigroup 3 of 5 stars	Lower Target		$125.00 ➝ $50.00	+106.19%
9/22/2022	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Buy	$525.00 ➝ $75.00	+127.27%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 11:12 AM ET.

NCNA Forecast - Frequently Asked Questions

What is NuCana's forecast for 2024?: According to the research reports of 2 Wall Street equities research analysts, the average twelve-month stock price forecast for NuCana is $150.00, with a high forecast of $150.00 and a low forecast of $150.00.
Should I buy or sell NuCana stock right now?: 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for NuCana in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" NCNA shares.
Does NuCana's stock price have much upside?: According to analysts, NuCana's stock has a predicted upside of 1,375.11% based on their 12-month stock forecasts.
What analysts cover NuCana?: NuCana has been rated by research analysts at Oppenheimer in the past 90 days.
Do Wall Street analysts like NuCana more than its competitors?: Analysts like NuCana more than other "medical" companies. The consensus rating for NuCana is Buy while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how NCNA compares to other companies.